Several studies have demonstrated a lack of ATGL-attenuated hyperlipidemia/atherosclerosis [8], in vitro [40], in vivo [41,42], or in human patients with metabolic syndrome [19]. The gene discussed is PNPLA2; the disease is metabolic syndrome.